Comparing Low and High Radioiodine Doses for Thyroid Cancer Treatment
Author Information
Author(s): Mäenpää Hanna, Heikkonen Jorma, Vaalavirta Leila, Tenhunen Mikko, Joensuu Heikki
Primary Institution: Helsinki University Central Hospital
Hypothesis
Is a higher dose of radioiodine more effective for thyroid ablation after surgery for cancer?
Conclusion
The study found no conclusive evidence that a higher dose of 3700 MBq is more effective than 1100 MBq for thyroid ablation.
Supporting Evidence
- Ablation was successful in 52% of patients receiving 1100 MBq and 56% receiving 3700 MBq.
- No significant difference in the number of repeat treatments needed between the two groups.
- Higher activity was associated with more nausea and longer hospital stays.
Takeaway
Doctors tested two doses of medicine to see which one works better for treating thyroid cancer, but they found that both doses worked about the same.
Methodology
160 adult patients with thyroid cancer were randomly assigned to receive either 1100 MBq or 3700 MBq of radioiodine after surgery.
Potential Biases
Potential biases due to the single-center design and the exclusion of certain patients.
Limitations
The study was conducted at a single center, which may limit the generalizability of the results.
Participant Demographics
Patients were adults diagnosed with papillary or follicular thyroid carcinoma, with a median age of 49 years.
Statistical Information
P-Value
0.61
Confidence Interval
95% CI, 41% to 63% for 1100 MBq; 95% CI, 45% to 67% for 3700 MBq
Statistical Significance
p=0.61
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website